• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Drug Safety Oversight Board Meeting, February 19, 2009

Public Summary

  • The Executive Director updated the Board on Public Health Advisories (PHAs), Early Communications about Ongoing Safety Reviews (ECs) and Information for Healthcare Professionals (HCP) sheets posted since the January 15, 2009, meeting (all available at: Index to Drug-Specific Information) and those risk communications currently in development.
  • The Drug Safety Oversight Board (DSB) discussed the development and utility of Pregnancy Exposure Registries, including disease-based and drug-based registries for collecting drug safety information.